Caribou Biosciences (CRBU) Change in Acquisitions & Divestments (2022 - 2025)
Caribou Biosciences has reported Change in Acquisitions & Divestments over the past 4 years, most recently at $61.8 million for Q4 2025.
- Quarterly Change in Acquisitions & Divestments fell 14.11% to $61.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $252.8 million through Dec 2025, down 36.39% year-over-year, with the annual reading at $252.8 million for FY2025, 36.39% down from the prior year.
- Change in Acquisitions & Divestments was $61.8 million for Q4 2025 at Caribou Biosciences, down from $68.4 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $120.7 million in Q3 2024 and troughed at $39.3 million in Q1 2022.
- The 4-year median for Change in Acquisitions & Divestments is $70.2 million (2024), against an average of $77.6 million.
- Year-over-year, Change in Acquisitions & Divestments skyrocketed 151.06% in 2023 and then plummeted 47.43% in 2025.
- A 4-year view of Change in Acquisitions & Divestments shows it stood at $89.7 million in 2022, then tumbled by 38.72% to $55.0 million in 2023, then surged by 30.81% to $71.9 million in 2024, then fell by 14.11% to $61.8 million in 2025.
- Per Business Quant, the three most recent readings for CRBU's Change in Acquisitions & Divestments are $61.8 million (Q4 2025), $68.4 million (Q3 2025), and $56.7 million (Q2 2025).